Woodline Partners’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
Other funds holding SEM
GCL
AA
DAM
PAMP
Woodline Partners's SEM Position: Q2 2026 in Review
Woodline Partners reduced its Select Medical (SEM) stake by 30% in Q2 2026, selling an estimated $6.02M and leaving 860,622 shares worth $14.2M. The position accounts for 0.04% of the portfolio, ranked #457.
Woodline Partners first reported a position in SEM in Q2 2023 and has held it in 9 quarters since. The position peaked at $25.4M in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- Woodline Partners held 860,622 shares of Select Medical worth $14.2M as of Q2 2026.
- Woodline Partners sold 365,573 Select Medical shares in Q2 2026, an estimated $6.02M.
- Select Medical made up 0.04% of Woodline Partners's portfolio in Q2 2026, its #457 holding.
- Woodline Partners first reported a position in Select Medical in Q2 2023 and has held it in 9 quarters since.
- Woodline Partners's Select Medical position peaked at $25.4M in Q2 2024.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.